Schedule 13G ownership disclosure

RAPT Therapeutics Inc

Common Stock $0.0001 par value per share · CUSIP: 75382E208

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nantahala Capital Management, LLC

    Shares: 623,282.00 · Class: 3.77%

  • Wilmot B. Harkey

    Shares: 623,282.00 · Class: 3.77%

  • Daniel Mack

    Shares: 623,282.00 · Class: 3.77%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-112626
Form type
SCHEDULE 13G/A
Filer
Nantahala Capital Management, LLC
CIK
CIK 1472322
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub